Limonin provokes hepatocellular carcinoma cells with stemness entry into cycle via activating PI3K/Akt signaling - 31/07/19


pages | 8 |
Iconographies | 9 |
Vidéos | 0 |
Autres | 0 |
Graphical abstract |
Highlights |
• | A new critical role of limonin in HCC stem cells progression is proposed. |
• | The mechanisms of limonin in HCC stem cells progression are further studied. |
• | A novel mode of regulation of PI3K/Akt signaling by limonin in HCC stem cells. |
• | The novel mechanism provides new potential drug for HCC. |
Abstract |
The inhibitory roles of limonin have been revealed in various tumors. However, the roles and related mechanism of limonin in hepatocellular carcinoma (HCC) progression are still confused. Here, we collected non-adherent spheroids formed by HCC cells and found that the proportion of spheroids in G0 phase was remarkably higher than that in HCC cells. Additionally, limonin increased EdU incorporation without affecting apoptosis in spheroids. Notably, upon limonin treatment, the proportion of spheroids in G0 was decreased and S/G2/M increased. Furthermore, we found that limonin attenuated the stemness of HCC cells, characterized as the decreased ALDH1 activity, stemness marker expression and spheroid formation ability. Moreover, an integrated transcriptional analysis based on RNA-sequencing data was employed to gain mechanistic insight into limonin functioning, and we found that the most significant pathways identified centered on PI3K/Akt signaling. qRT-PCR and western blot obtained the consistent results. Overall, these data suggest that limonin attenuates the stemness of HCC cells by reducing cellular quiescence through activating PI3K/Akt signaling.
Le texte complet de cet article est disponible en PDF.Keywords : Limonin, Hepatocellular carcinoma, Stemness, PI3K/Akt, Cellular quiescence
Plan
Vol 117
Article 109051- septembre 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?